# Future Best Buys Can and Should Do More: Comment on "Barriers and Opportunities for WHO ‘Best Buys’ Non-Communicable Disease Policy Adoption and Implementation From a Political Economy Perspective: A Complexity Systematic Review"

## TL;DR

This paper discusses how WHO's cost-effective NCD prevention strategies face political and industry challenges and suggests improvements for future policies.

## Contribution

The paper proposes that future 'best buys' should prioritize structural interventions and equity-focused strategies.

## Key findings

- Industry opposition and commercial determinants of health hinder NCD policy adoption.
- Current best buys may operate inequitably and fail to address the global obesity syndemic.
- Structural interventions and equity-focused strategies are needed in future revisions.

## Abstract

Over a decade has passed since the World Health Organization (WHO) proposed a set of "best buys" for the prevention of non-communicable diseases (NCDs). Loffreda and colleagues’ review describes how, despite the cost-effectiveness of these interventions, their adoption is often complex and governments face many challenges in both implementing and maintaining NCD prevention policies. Industry opposition and the commercial determinants of health (CDoH) remain significant challenges to an effective NCD response. In addition, the best buys may operate inequitably and are often unable to respond to the interrelated challenges posed by the global syndemic of obesity. We suggest that the next revision of the best buys adopts a more integrated approach that prioritize structural interventions, equity-focused strategies, and mechanisms to counteract industry interference.